DUX (DUX4 in human) was first identified to be aberrantly expressed in facioscapulohumeral muscular dystrophy (FSHD) in humans, a disorder that is characterized by an unusually high transcriptional output of ERVs [166]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.